BTIG Research decreased their Q1 2025 earnings estimates for shares of Meritage Homes in a report issued on Tuesday, February ...
HOPE Therapeuticsâ„¢, Inc. ("HOPE"), a medical and technology driven company, and a wholly-owned subsidiary of NRx ...
BTIG notes that Bloomberg reported earlier that Buy-rated Paysafe (PSFE) is exploring a sale after receiving takeover interest. The article ...
BTIG announced today that it will host its annual MedTech, Digital Health, Life Science and Diagnostic Tools Conference on Tuesday, February 11 through Wednesday, February 12, 2025. The firm expects ...
BTIG analyst Justin Zelin downgraded Kura Oncology (KURA) to Neutral from Buy without a price target The firm cites a lack of clarity and ...
The oft-maligned skinny jean has crept back onto the runway and is headed for a comeback as soon as this fall.
BTIG analyst Janine Stichter adjusted the price target for Steven Madden (NASDAQ: NASDAQ:SHOO) shares to $46.00, down from ...
NEW YORK--(BUSINESS WIRE)--BTIG announced today that it will host its annual MedTech, Digital Health, Life Science and Diagnostic Tools Conference on Tuesday, February 11 through Wednesday ...
ROCKAWAY, N.J., Feb. 04, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today its participation in the 12th Annual ...
On Thursday, BTIG analyst Justin Zelin downgraded Kura Oncology stock (NASDAQ:KURA) from Buy to Neutral. Zelin cited concerns over the recent KOMET-001 study results for the company's drug ...
Treace provides technology that facilitates Lapiplasty bunion surgery and related midfoot deformities. The company recently ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results